What questions should I ask my oncologist about early stage Multiple Myeloma
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Questions to Ask Your Oncologist About Early Stage Multiple Myeloma
Based on the NCCN Guidelines for Patients and expert recommendations, here are the most important questions to help you understand your situation and make informed decisions about your care:
UNDERSTANDING YOUR DIAGNOSIS
"What's driving my myeloma?"
- Ask your doctor to explain what specific genetic or chromosomal abnormalities your myeloma cells have (like deletions, duplications, or translocations). According to NCCN Guidelines, these abnormal changes help determine whether your myeloma might come back quickly or respond well to treatment.
"What stage is my myeloma, and what does that mean for me?"
- Understanding whether you have smoldering myeloma (early stage with fewer symptoms) versus active myeloma helps determine urgency of treatment.
"Have I had all the necessary tests to fully understand my cancer?"
- Ask specifically about: bone marrow biopsy results, FISH testing (which looks for chromosomal abnormalities), imaging scans (PET/CT or MRI), and blood/urine protein tests. The NCCN Guidelines emphasize that comprehensive testing helps plan the best treatment.
ABOUT YOUR TREATMENT OPTIONS
"What are ALL my treatment options, not just the standard one?"
- According to NCCN Guidelines, early stage myeloma typically involves multi-drug combinations (often 3-4 medications together). Ask your doctor to explain each option available to you, including:
- Targeted therapies (proteasome inhibitors like bortezomib)
- Immunomodulators (like lenalidomide)
- Monoclonal antibodies (like daratumumab)
- Corticosteroids
- Whether a hematopoietic cell transplant (stem cell transplant) might be part of your plan
"Will I be a candidate for a stem cell transplant, and if so, when?"
- NCCN Guidelines note that testing for transplant eligibility happens early in treatment. This is important because some chemotherapy drugs can make it harder to collect stem cells later, so your doctor needs to plan ahead.
"What's the goal of my treatment—remission, disease control, or something else?"
- Understanding whether the goal is to eliminate all detectable myeloma or to keep it stable and manageable helps you set realistic expectations.
ABOUT SIDE EFFECTS AND QUALITY OF LIFE
"What are the common side effects of the treatment you're recommending, and how can we manage them?"
- Different myeloma drugs cause different side effects. Ask specifically about:
- Blood cell counts (anemia, low white blood cells, low platelets)
- Neuropathy (numbness/tingling in hands or feet)
- Blood clots
- Nausea, fatigue, or other symptoms
- How these will be monitored and treated
"How will treatment affect my daily life—work, activities, travel?"
- Ask about the schedule (how often you'll receive treatment), whether it's pills, injections, or IV infusions, and what to expect in terms of time commitment.
MONITORING AND FOLLOW-UP
"How will we know if the treatment is working?"
- According to NCCN Guidelines, follow-up tests typically include blood tests for M proteins (abnormal antibodies), free light chains, and imaging scans. Ask how often you'll have these tests and what results would indicate the treatment needs to change.
"What happens if my myeloma doesn't respond to this treatment or comes back?"
- NCCN Guidelines note that myeloma often requires multiple treatments over time. Understanding your options if the first treatment doesn't work helps you feel prepared.
"How often will I need follow-up appointments and tests?"
- Ask about the schedule for blood work, imaging, and office visits, both during and after treatment.
GETTING THE BEST CARE
"Should I get a second opinion from a myeloma specialist?"
- NCCN Guidelines strongly recommend seeking care from someone experienced in treating myeloma. Even if you're happy with your current doctor, a second opinion from a myeloma specialist can be valuable and is a normal part of cancer care.
"Are there clinical trials available for my specific type of myeloma?"
- Ask if your doctor knows about clinical trials—either at your institution or elsewhere—that might be appropriate for you. Clinical trials can offer access to newer treatments.
"What support services are available to me?"
- Ask about counseling, support groups, financial assistance, and other resources to help you manage treatment and side effects.
KEY TAKEAWAY
According to the NCCN Guidelines for Patients, you have an important role in your care. The guidelines emphasize: "With better understanding, you'll be more prepared to discuss your care with your team and share your concerns. Many people feel more satisfied, confident, and less anxious when they play an active role in their care."
Don't hesitate to ask your doctor to explain things in simpler language if needed, and bring a trusted friend or family member to appointments to help you remember information and ask follow-up questions.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Multiple Myeloma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Multiple Myeloma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What is the life expectancy for multiple myeloma cancer
I understand this is one of the most important questions you might have. Let me share what the current medical evidence shows, while being clear about
What is the 5-year survival rate for multiple myeloma
I appreciate this important question, but I need to be transparent with you: the NCCN Guidelines for Patients materials I have access to don't include
What is the average survival rate for multiple myeloma by stage
I appreciate this important question. However, I need to be direct with you: the NCCN Guidelines for Patients that I have access to do not include spe